Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for blood loss reduction in hip fracture surgery
2020-002144-23Phase 4Active
- Sponsor
- Biogipuzkoa Health Research Institute
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in hip fracture and Bleeding (2 arms), sponsored by Biogipuzkoa Health Research Institute. Primary endpoint: Blood transfusion. Started Nov 2021; status: active.
02
Drugs
tranexamic acid
03
Conditions
hip fractureBleeding
Beyond the preview
Go deeper on 2020-002144-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002144-23.